The year 2020 has seen a lot of development in the way we do business such as new regulations and smarter solutions to solve old and new challenges. PwC has identified the following hot topics for Pharma & Life Sciences which need our special attention:
Discover PwC’s four cutting edge digital tax & regulatory solutions and how they can add value to your business, help you complying with new laws, stay up to date with upcoming changes in legislation and regulatory.
As the COVID-19 situation develops, tax and regulatory specialists within the pharmaceutical & life sciences industry are increasingly facing complex challenges. Efficient and pragmatic solutions have to be realised, with fewer resources, in line with the changing local legislation.
The exchange of information is the best practice in this industry to support and inspire you in your daily business.
Do you face troubles in order to be up to
date with all the required legislation changes in various countries in the
Regulatory Pharma & Life Sciences field AND combine it with your supply
chain and tax strategy?
I am happy to inform you that we have recently
launched our Pharma & Life Sciences Regulatory Radar, to strive to assist
you in that regard.
Are you a pharmaceutical company selling drugs outlined in the list of special drugs and therapies (“Spezialitätenliste”) in Switzerland? If yes, you could benefit from the following information in connection with Swiss VAT.